Dexcom held its 2024 Annual Meeting of Stockholders and the following matters were voted on: election of directors, ratification of independent registered public accounting firm, advisory vote to approve named executive officer compensation, stockholder proposal regarding pay equity disclosure, and stockholder proposal regarding transparency in lobbying.